KFF Health News’ ‘What the Health?’: Schrödinger’s Government Shutdown
The Host Julie Rovner KFF Health News @jrovner @julierovner.bsky.social Read Julie’s stories. Julie Rovner is…
KFF Health News’ ‘What the Health?’: Schrödinger’s Government Shutdown
The Host Julie Rovner KFF Health News @jrovner @julierovner.bsky.social Read Julie’s stories. Julie Rovner is chief Washington correspondent and host of KFF Health News’ weekly health policy news podcast, “What the Health?” A noted expert on health policy issues, Julie is the author of the critically praised reference book “Health Care Politics and Policy A…
Shop and Compare: Online Health Insurance Options in California
[Sponsored] Here are some of the top online health insurance options worth exploring — each designed to simplify coverage decisions while meeting California’s high standards for accessibility and compliance. The post Shop and Compare: Online Health Insurance Options in California appeared first on MedCity News.
Bridging Healthcare’s Data Gaps as Care Expands Beyond Traditional Settings
Outpatient facilities and microhospitals improve care access, but as patients receive care across more places, data becomes more fragmented, requiring an adapted approach to non-interventional research The post Bridging Healthcare’s Data Gaps as Care Expands Beyond Traditional Settings appeared first on MedCity News.
Returning Time to Clinicians Is Why Innovation Matters
Simplifying these labor-intensive and iterative processes through automation enables providers to spend more time on direct patient care instead of hunting through charts and sitting on hold with insurance companies. The post Returning Time to Clinicians Is Why Innovation Matters appeared first on MedCity News.
An Age-Old Fear Grows More Common: ‘I’m Going To Die Alone’
This summer, at dinner with her best friend, Jacki Barden raised an uncomfortable topic: the possibility that she might die alone. “I have no children, no husband, no siblings,” Barden remembered saying. “Who’s going to hold my hand while I die?” Barden, 75, never had children. She’s lived on her own in western Massachusetts since…
Un miedo ancestral cada vez más común: “Voy a morir solo”
Este verano, durante una cena con su mejor amiga, Jacki Barden habló de un tema incómodo: la posibilidad de morir sola. “No tengo hijos, ni esposo, ni hermanos”, recordó haber dicho Barden. “¿Quién va a sostener mi mano cuando muera?”. Barden, de 75 años, nunca tuvo hijos. Vive sola en el oeste de Massachusetts desde…
It’s a Bird! It’s a Plane! It’s a Chemtrail? New Conspiracy Theory Takes Wing at Kennedy’s HHS
While plowing a wheat field in rural Washington state in the 1990s, William Wallace spotted a gray plane overhead that he believed was releasing chemicals to make him sick. The rancher began to suspect that all white vapor trails from aircraft might be dangerous. He shared his concern with reporters, acknowledging it sounded a little…
The value of a positive attitude
…is large. At least according to a recent paper by Graham and Mujcic (2025). The focus of the paper is on the on the long term health, emotional and economic impacts of having a hopeful attitude. Hope has agentic properties which are relevant to people’s future outcomes. Following 25,000 randomly sampled Australian adults over a…
Another Major Strike at Kaiser Permanente: What’s at Stake This Time
Tens of thousands of Kaiser Permanente workers in California and Hawaii have gone on strike, demanding safer staffing levels and higher pay. The dispute underscores growing tensions in healthcare labor as unions raise concerns about patient safety, ongoing burnout and ever-increasing pay for executives. The post Another Major Strike at Kaiser Permanente: What’s at Stake…
Novo Nordisk Gets New Complement System Approach to Rare Diseases With Deal for Omeros Drug
Novo Nordisk is paying $240 million up front for global rights to zaltenibart, an Omeros drug that blocks the MASP-3 protein to treat diseases caused by excessive activity of the complement system. This antibody drug is on track for pivotal testing that could show superiority over blockbuster AstraZeneca drugs that are standard treatments for a…
